6401 - 6450 of 8808 Results
Title
Year
-
OPENTitle: Non-motor Clinical and Biomarker Predictors Enable High Cross-Validated Accuracy Detection of Early PD but Lesser Cross-Validated Accuracy Detection of Scans Without Evidence of Dopaminergic DeficitJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00364Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00364/pdfCitation Count: 11
-
OPENTitle: Mitochondrial tRNA methylation in Alzheimer’s disease and progressive supranuclear palsyJournal Name: BMC Medical GenomicsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12920-020-0727-9Best OA location URL: https://bmcmedgenomics.biomedcentral.com/track/pdf/10.1186/s12920-020-0727-9Citation Count: 16
-
OPENTitle: Neuromechanical Assessment of Activated vs. Resting Leg Rigidity Using the Pendulum Test Is Associated With a Fall History in People With Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.602595Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.602595/pdfCitation Count: 3
- Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease2020OPENTitle: Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2028End Page: 2037Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28202Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28202Citation Count: 100
-
OPENTitle: Differential transcript usage unravels gene expression alterations in Alzheimer’s disease human brainsJournal Name: npj Aging and Mechanisms of DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41514-020-00052-5Best OA location URL: https://www.nature.com/articles/s41514-020-00052-5.pdfCitation Count: 82
-
OPENTitle: A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human LymphoblastsJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 2Start Page: 480End Page: 480Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10020480Best OA location URL: https://www.mdpi.com/2073-4409/10/2/480/pdf?version=1614234637Citation Count: 19
-
OPENTitle: Probable REM sleep behavior disorder is associated with longitudinal cortical thinning in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00164-zBest OA location URL: https://www.nature.com/articles/s41531-021-00164-z.pdfCitation Count: 26
-
OPENTitle: Thalamic morphology predicts the onset of freezing of gait in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00163-0Best OA location URL: https://www.nature.com/articles/s41531-021-00163-0.pdfCitation Count: 30
-
OPENTitle: The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00162-1Best OA location URL: https://www.nature.com/articles/s41531-021-00162-1.pdfCitation Count: 18
-
OPENTitle: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of LevodopaJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/9716317Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/9716317.pdfCitation Count: 20
- APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease2021OPENTitle: APOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.631145Best OA location URL: https://doi.org/10.3389/fneur.2021.631145Citation Count: 41
-
OPENTitle: Validation of a Parkinson Disease Predictive Model in a Population-Based StudyJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/2857608Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/2857608.pdfCitation Count: 10
-
OPENTitle: Symptom burden among individuals with Parkinson diseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page: 65End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000746Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7057075Citation Count: 39
-
OPENTitle: Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson diseaseJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 10Issue #: 1Start Page: 40End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/cpj.0000000000000702Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7057070Citation Count: 27
-
OPENTitle: Improvement of classification performance of Parkinson’s disease using shape features for machine learning on dopamine transporter single photon emission computed tomographyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 1Start Page: e0228289End Page: e0228289Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0228289Best OA location URL: https://doi.org/10.1371/journal.pone.0228289Citation Count: 34
-
OPENTitle: Analysis of common and rare VPS13C variants in late-onset Parkinson diseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000385Best OA location URL: https://ng.neurology.org/content/nng/6/1/385.full.pdfCitation Count: 21
-
OPENTitle: Brain Damage With Heart FailureJournal Name: Circulation ResearchPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 126Issue #: 6Start Page: 750End Page: 764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1161/circresaha.119.315813Best OA location URL: https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.119.315813Citation Count: 72
-
OPENTitle: Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive declineJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008683Best OA location URL: https://n.neurology.org/content/neurology/94/4/e376.full.pdfCitation Count: 23
-
OPENTitle: Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALSJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.642324Best OA location URL: https://doi.org/10.3389/fnins.2021.642324Citation Count: 8
-
OPENTitle: Genetic control of the human brain proteomeJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 108Issue #: 3Start Page: 400End Page: 410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ajhg.2021.01.012Best OA location URL: http://www.cell.com/article/S0002929721000124/pdfCitation Count: 86
-
OPENTitle: Brain MRI Reveals Ascending Atrophy in Parkinson's Disease Across SeverityJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2019.01329Best OA location URL: https://doi.org/10.3389/fneur.2019.01329Citation Count: 21
-
OPENTitle: Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 1Start Page: 234End Page: 248Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz350Best OA location URL: https://academic.oup.com/brain/article-pdf/143/1/234/32757155/awz350.pdfCitation Count: 215
-
OPENTitle: Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s diseaseJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0574-0Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-019-0574-0Citation Count: 32
-
OPENTitle: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)Journal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 127Issue #: 1Start Page: 51End Page: 59Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00702-019-02125-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00702-019-02125-6.pdfCitation Count: 15
-
OPENTitle: The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportionJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 139Issue #: 1Start Page: 45End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-019-02066-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6942643Citation Count: 73
-
OPENTitle: Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue SamplesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.620899Best OA location URL: https://doi.org/10.3389/fnins.2021.620899Citation Count: 38
-
OPENTitle: Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s diseaseJournal Name: Brain PathologyPublisher: WileyVol: 30Issue #: 4Start Page: 794End Page: 810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.12842Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.12842Citation Count: 13
-
OPENTitle: Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive DeclineJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.626974Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/85247Citation Count: 20
- Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research2021OPENTitle: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchJournal Name: TrialsPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13063-021-05273-xBest OA location URL: https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-021-05273-xCitation Count: 33
-
OPENTitle: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 4Start Page: 534End Page: 540Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13168Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/134137Citation Count: 24
- Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy2019OPENTitle: Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear PalsyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 10Start Page: e0223621End Page: e0223621Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0223621Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0223621&type=printableCitation Count: 14
- Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease2019OPENTitle: Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008677Best OA location URL: https://n.neurology.org/content/neurology/94/7/e718.full.pdfCitation Count: 29
-
OPENTitle: Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: implications for disease modeling and therapeutic developmentJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-63559-7Best OA location URL: https://www.nature.com/articles/s41598-020-63559-7.pdfCitation Count: 60
-
OPENTitle: The turning and barrier course reveals gait parameters for detecting freezing of gait and measuring the efficacy of deep brain stimulationJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 4Start Page: e0231984End Page: e0231984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0231984Best OA location URL: https://doi.org/10.1371/journal.pone.0231984Citation Count: 35
-
OPENTitle: Objective measurement in Parkinson’s disease: a descriptive analysis of Parkinson’s symptom scores from a large population of patients across the world using the Personal KinetiGraph®Journal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-020-00087-6Best OA location URL: https://clinicalmovementdisorders.biomedcentral.com/track/pdf/10.1186/s40734-020-00087-6Citation Count: 29
-
OPENTitle: CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson’s disease: a study in LRRK2 mutation carriersJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-020-00192-4Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/77562Citation Count: 48
-
OPENTitle: Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior DisorderJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 349End Page: 349Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00349Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00349/pdfCitation Count: 26
-
OPENTitle: Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucoseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 15Issue #: 5Start Page: e0230815End Page: e0230815Publication Date:Open Access(OA) Status: OPENLicense: cc0, cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0230815Best OA location URL: https://escholarship.org/uc/item/01585271Citation Count: 33
-
OPENTitle: Unique white matter structural connectivity in early-stage drug-naive Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000008867Best OA location URL: https://n.neurology.org/content/neurology/94/8/e774.full.pdfCitation Count: 38
-
OPENTitle: Low Cholesterol Level Linked to Reduced Semantic Fluency Performance and Reduced Gray Matter Volume in the Medial Temporal LobeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.00057/pdfCitation Count: 19
-
OPENTitle: Pallidal stimulation as treatment for camptocormia in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00151-wBest OA location URL: https://www.nature.com/articles/s41531-020-00151-w.pdfCitation Count: 19
-
OPENTitle: Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementiaJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12106Best OA location URL: https://doi.org/10.1002/trc2.12106Citation Count: 36
-
OPENTitle: The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 2Start Page: 448End Page: 454Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-020-10156-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-020-10156-3.pdfCitation Count: 25
-
OPENTitle: Walking Speed Reliably Measures Clinically Significant Changes in Gait by Directional Deep Brain StimulationJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.618366Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.618366/pdfCitation Count: 9
-
OPENTitle: Risk factors for possible REM sleep behavior disordersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 16Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010610Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7713784Citation Count: 21
-
OPENTitle: Diet pattern and prodromal features of Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010523Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7713746Citation Count: 72
-
OPENTitle: Association of CSF Aβ, amyloid PET, and cognition in cognitively unimpaired elderly adultsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010596Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7713747Citation Count: 41
- Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omics2021OPENTitle: Systematic characterization of human gut microbiome-secreted molecules by integrated multi-omicsJournal Name: ISME CommunicationsPublisher: Oxford University Press (OUP)Vol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s43705-021-00078-0Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/105980Citation Count: 8
-
OPENTitle: STN Versus GPi Deep Brain Stimulation for Action and Rest Tremor in Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.578615Best OA location URL: https://doi.org/10.3389/fnhum.2020.578615Citation Count: 38
-
OPENTitle: Disease modifying treatment trials in Parkinson’s disease: how to balance expectations and interests of patients, physicians and industry partners?Journal Name: Neurological Research and PracticePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s42466-020-00076-yBest OA location URL: https://neurolrespract.biomedcentral.com/track/pdf/10.1186/s42466-020-00076-yCitation Count: 3